OPEN END TURBO OPTIONSSCHEIN SHORT - MEDTRONIC Share Price

Certificat

DE000GG2F3J6

Market Closed - BOERSE MUENCHEN 11:57:15 28/06/2024 pm IST
1.523 EUR -4.03% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - MEDTRONIC
Current month+10.68%
1 month+20.30%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/24/28 1.523 -4.03%
27/24/27 1.587 +6.87%
26/24/26 1.485 +0.75%
25/24/25 1.474 +8.14%
24/24/24 1.363 -1.09%

Real-time BOERSE MUENCHEN

Last update June 28, 2024 at 11:57 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying MEDTRONIC PLC
Issuer Goldman Sachs
WKN GG2F3J
ISINDE000GG2F3J6
Date issued 11/01/2024
Strike 95.25 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.83
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.63
Lowest since issue 0.699

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
78.71 USD
Average target price
94.02 USD
Spread / Average Target
+19.46%
Consensus